Cargando…
Intravesical Instillation of Azacitidine Suppresses Tumor Formation through TNF-R1 and TRAIL-R2 Signaling in Genotoxic Carcinogen-Induced Bladder Cancer
SIMPLE SUMMARY: Approximately 70% of all bladder cancer is diagnosed as non-muscle invasive bladder cancer and can be treated by transurethral resection of the bladder tumor, followed by intravesical instillation chemotherapy. Bacille Calmette-Guérin (BCG) is the first-line agent for intravesical in...
Autores principales: | Wang, Shao-Chuan, Chang, Ya-Chuan, Wu, Min-You, Yu, Chia-Ying, Chen, Sung-Lang, Sung, Wen-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392848/ https://www.ncbi.nlm.nih.gov/pubmed/34439091 http://dx.doi.org/10.3390/cancers13163933 |
Ejemplares similares
-
Intravesical Instillation of Mitomycin C: A Cause of Delayed Bladder Perforation?
por: Penna, Marta, et al.
Publicado: (2012) -
Systemic BCG‐osis following intravesical BCG instillation for bladder carcinoma
por: Liaw, Frank, et al.
Publicado: (2017) -
Local Immune Stimulation by Intravesical Instillation of Baculovirus to Enable Bladder Cancer Therapy
por: Ang, Wei Xia, et al.
Publicado: (2016) -
Intravesical Instillation of Norketamine, a Ketamine Metabolite, and Induced Bladder Functional Changes in Rats
por: Yeh, Chung-Hsin, et al.
Publicado: (2021) -
Randomized study of intravesical pirarubicin chemotherapy with low and intermediate-risk nonmuscle-invasive bladder cancer in Japan: Comparison of a single immediate postoperative intravesical instillation with short-term adjuvant intravesical instillations after transurethral resection
por: Naya, Yoshio, et al.
Publicado: (2018)